vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Hillenbrand, Inc. (HI). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $550.2M, roughly 1.5× Hillenbrand, Inc.). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs -0.4%, a 0.9% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -22.2%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -16.3%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Hillenbrand, Inc. is a global diversified industrial firm that designs, manufactures, and distributes specialized processing equipment and durable industrial solutions. It serves food & beverage, agriculture, manufacturing, waste management sectors, with operations across North America, Europe, and APAC.
ACHC vs HI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $550.2M |
| Net Profit | $4.5M | $-2.2M |
| Gross Margin | — | 33.4% |
| Operating Margin | — | -2.2% |
| Net Margin | 0.5% | -0.4% |
| Revenue YoY | 7.5% | -22.2% |
| Net Profit YoY | -50.8% | -134.4% |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $550.2M | ||
| Q3 25 | $851.6M | $652.1M | ||
| Q2 25 | $869.2M | $598.9M | ||
| Q1 25 | $770.5M | $715.9M | ||
| Q4 24 | $774.2M | $706.9M | ||
| Q3 24 | $815.6M | $837.6M | ||
| Q2 24 | $796.0M | $786.6M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $-2.2M | ||
| Q3 25 | $36.2M | $75.7M | ||
| Q2 25 | $30.1M | $1.9M | ||
| Q1 25 | $8.4M | $-40.9M | ||
| Q4 24 | $32.6M | $6.4M | ||
| Q3 24 | $68.1M | $14.6M | ||
| Q2 24 | $78.5M | $-248.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 33.4% | ||
| Q3 25 | — | 34.8% | ||
| Q2 25 | — | 33.8% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 33.2% | ||
| Q3 24 | — | 34.4% | ||
| Q2 24 | — | 33.9% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | -2.2% | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 5.8% | 1.8% | ||
| Q1 25 | 1.7% | -6.2% | ||
| Q4 24 | 4.9% | 2.2% | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.4% | -32.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | -0.4% | ||
| Q3 25 | 4.3% | 11.6% | ||
| Q2 25 | 3.5% | 0.3% | ||
| Q1 25 | 1.1% | -5.7% | ||
| Q4 24 | 4.2% | 0.9% | ||
| Q3 24 | 8.4% | 1.7% | ||
| Q2 24 | 9.9% | -31.6% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $1.07 | ||
| Q2 25 | $0.33 | $0.03 | ||
| Q1 25 | $0.09 | $-0.58 | ||
| Q4 24 | $0.36 | $0.09 | ||
| Q3 24 | $0.74 | $0.20 | ||
| Q2 24 | $0.85 | $-3.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $173.1M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $1.4B |
| Total Assets | $5.5B | $4.5B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $173.1M | ||
| Q3 25 | $118.7M | $164.8M | ||
| Q2 25 | $131.4M | $162.8M | ||
| Q1 25 | $91.2M | $458.4M | ||
| Q4 24 | $76.3M | $208.0M | ||
| Q3 24 | $82.1M | $199.3M | ||
| Q2 24 | $77.2M | $223.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $1.7B | ||
| Q1 25 | $2.2B | $1.9B | ||
| Q4 24 | $2.0B | $1.9B | ||
| Q3 24 | $1.9B | $1.9B | ||
| Q2 24 | $1.8B | $2.1B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $3.1B | $1.4B | ||
| Q2 25 | $3.1B | $1.3B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $3.1B | $1.4B | ||
| Q3 24 | $3.0B | $1.4B | ||
| Q2 24 | $3.0B | $1.4B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $4.5B | ||
| Q3 25 | $6.4B | $4.5B | ||
| Q2 25 | $6.3B | $4.7B | ||
| Q1 25 | $6.1B | $4.8B | ||
| Q4 24 | $6.0B | $5.1B | ||
| Q3 24 | $5.9B | $5.2B | ||
| Q2 24 | $5.7B | $5.3B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 1.10× | ||
| Q2 25 | 0.74× | 1.27× | ||
| Q1 25 | 0.72× | 1.44× | ||
| Q4 24 | 0.64× | 1.38× | ||
| Q3 24 | 0.62× | 1.33× | ||
| Q2 24 | 0.62× | 1.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $-27.4M |
| Free Cash FlowOCF − Capex | — | $-31.6M |
| FCF MarginFCF / Revenue | — | -5.7% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-27.4M | ||
| Q3 25 | $73.2M | $67.7M | ||
| Q2 25 | $133.5M | $-1.5M | ||
| Q1 25 | $11.5M | $1.3M | ||
| Q4 24 | $116.7M | $-11.3M | ||
| Q3 24 | $163.1M | $166.5M | ||
| Q2 24 | $171.1M | $45.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-31.6M | ||
| Q3 25 | $-63.0M | $58.6M | ||
| Q2 25 | $-34.2M | $-11.2M | ||
| Q1 25 | $-163.2M | $-8.0M | ||
| Q4 24 | $-86.8M | $-21.5M | ||
| Q3 24 | $-27.1M | $153.4M | ||
| Q2 24 | $16.9M | $29.7M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -5.7% | ||
| Q3 25 | -7.4% | 9.0% | ||
| Q2 25 | -3.9% | -1.9% | ||
| Q1 25 | -21.2% | -1.1% | ||
| Q4 24 | -11.2% | -3.0% | ||
| Q3 24 | -3.3% | 18.3% | ||
| Q2 24 | 2.1% | 3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.8% | ||
| Q3 25 | 16.0% | 1.4% | ||
| Q2 25 | 19.3% | 1.6% | ||
| Q1 25 | 22.7% | 1.3% | ||
| Q4 24 | 26.3% | 1.4% | ||
| Q3 24 | 23.3% | 1.6% | ||
| Q2 24 | 19.4% | 2.0% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | 0.89× | ||
| Q2 25 | 4.43× | -0.79× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | -1.77× | ||
| Q3 24 | 2.39× | 11.40× | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
HI
| Transferred At Point In Time | $256.5M | 47% |
| Transferred Over Time | $207.1M | 38% |
| Molding Technology Solutions | $86.6M | 16% |
